SPY320.28+8.92 2.86%
DIA272.17+8.84 3.36%
IXIC9,837.43+221.62 2.30%

Adamis Pharmaceuticals Q1 EPS $(0.110) Misses $(0.040) Estimate, Sales $4.663M Miss $6.870M Estimate

Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.110) per share which missed the analyst consensus estimate of $(0.040) by 175 percent. This is a 42.11 percent increase over losses of $(0.190) per

Benzinga · 05/18/2020 20:39

Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.110) per share which missed the analyst consensus estimate of $(0.040) by 175 percent. This is a 42.11 percent increase over losses of $(0.190) per share from the same period last year. The company reported quarterly sales of $4.663 million which missed the analyst consensus estimate of $6.870 million by 32.13 percent. This is a 4.95 percent decrease over sales of $4.906 million the same period last year.